Clinical Trials Logo

Citation(s)

  •   Guerra-Vazquez CM, Martinez-Avila M, Guajardo-Flores D, Antunes-Ricardo M
    Punicic Acid and Its Role in the Prevention of Neurological Disorders: A Review. Foods. 2022 Jan 18;11(3):252. doi: 10.3390/foods11030252.
  •   Krucoff MO, Rahimpour S, Slutzky MW, Edgerton VR, Turner DA
    Enhancing Nervous System Recovery through Neurobiologics, Neural Interface Training, and Neurorehabilitation. Front Neurosci. 2016 Dec 27;10:584. doi: 10.3389/fnins.2016.00584. eCollection 2016.
  •   Krug E, Cieza A
    Strengthening Health Systems to Provide Rehabilitation Services. Ann Rehabil Med. 2017 Apr;41(2):169-170. doi: 10.5535/arm.2017.41.2.169. Epub 2017 Apr 27. No abstract available.
  •   Lexell J, Brogardh C
    The use of ICF in the neurorehabilitation process. NeuroRehabilitation. 2015;36(1):5-9. doi: 10.3233/NRE-141184.
  •   McDowell FH
    Neurorehabilitation. West J Med. 1994 Sep;161(3):323-7. No abstract available.
  •   Ona ED, Cano-de la Cuerda R, Sanchez-Herrera P, Balaguer C, Jardon A
    A Review of Robotics in Neurorehabilitation: Towards an Automated Process for Upper Limb. J Healthc Eng. 2018 Apr 1;2018:9758939. doi: 10.1155/2018/9758939. eCollection 2018.
  •   Sanders T, Liu Y, Buchner V, Tchounwou PB
    Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health. 2009 Jan-Mar;24(1):15-45. doi: 10.1515/reveh.2009.24.1.15.
  •   Tempest S, Jefferson R
    Engaging with clinicians to implement and evaluate the ICF in neurorehabilitation practice. NeuroRehabilitation. 2015;36(1):11-5. doi: 10.3233/NRE-141185.
  •   van den Broek MD
    Why does neurorehabilitation fail? J Head Trauma Rehabil. 2005 Sep-Oct;20(5):464-73. doi: 10.1097/00001199-200509000-00007.
  •   Wade DT
    What is rehabilitation? An empirical investigation leading to an evidence-based description. Clin Rehabil. 2020 May;34(5):571-583. doi: 10.1177/0269215520905112. Epub 2020 Feb 10.
  •   Zis P, Hadjivassiliou M
    Treatment of Neurological Manifestations of Gluten Sensitivity and Coeliac Disease. Curr Treat Options Neurol. 2019 Feb 26;21(3):10. doi: 10.1007/s11940-019-0552-7.

Clinical Assessment And Treatment Preferences of Physiotherapists Working in Neurorehabilitation: A Research From Turkey

Details for clinical trial NCT05855096